ReviewMetabolic brain disease2012

Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Michael MaesPubMed ↗Publisher ↗

No numbers read from the abstract.